NCT06228274View on ClinicalTrials.gov

Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee

CompletedOBSERVATIONAL
Enrollment

218

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

March 31, 2017

Conditions
Knee Osteoarthritis
Interventions
DEVICE

ARTHRUM 2.5%

ARTHRUM 2.5%

Sponsors

Lead Sponsor

LCA Pharmaceutical
All Listed Sponsors
collaborator

BIOSTATEM

UNKNOWN

lead

LCA Pharmaceutical

INDUSTRY